A Long Term Safety Extension Study (CHS-0214-05)

Summary

An Open-label, Safety Extension Study (OLSES) evaluating the longer-term safety and durability of response of subjects who completed 48 weeks of evaluations in the confirmatory safety and efficacy studies, CHS 0214-02 or CHS-0214-04, evaluating CHS-0214 in patients with rheumatoid arthritis (RA) and plaque psoriasis (PsO), respectively.

Timeline

Start

2015-07

Primary completion

2017-09

Completion

2017-10

Drugs

Indications